Indication
Neurogenic Bowel
3 clinical trials
1 product
Clinical trial
Pharmacokinetics of Neostigmine and Glycopyrrolate After Intravenous and Transcutaneous Administration by IontophoresisStatus: Active (not recruiting), Estimated PCD: 2023-02-17
Product
Neostigmine + GlycopyrrolateClinical trial
Neostigmine and Glycopyrrolate by Iontophoresis to Induce Bowel EvacuationStatus: Active (not recruiting), Estimated PCD: 2022-10-25
Clinical trial
Safety and Pharmacokinetics of Positively Charged Compounds by Transdermal Administration by a Novel Wireless Iontophoresis DeviceStatus: Recruiting, Estimated PCD: 2025-02-15